Abstract
Oestrogen receptor alpha (ER-alpha) gene has two specific promoters, distal (P0) and proximal (P1), which induce almost identical transcripts in size due to different splicing. We examined the methylation at both promoter regions of the ER-alpha gene using HpaII, a methylation-sensitive restriction enzyme, prior to polymerase chain reaction (PCR) amplification. To confirm the results of PCR-based methylation analysis, Southern hybridization was also performed. Twenty of 29 patients with ER-alpha-positive tumours and five of 27 with ER-alpha-negative tumours were unmethylated at the P1 promoter region of the ER-alpha gene. The incidence of methylation was highly negatively correlated with ER-alpha expression (P = 0.0002). A similarly negative correlation was observed at the P0 promoter region of the ER-alpha gene (P = 0.0154). Additionally, the tumours with the ER-alpha gene hypermethylated at both promoter regions had definitely negative ER-alpha values. It was suggested that this epigenetic change might control ER-alpha expression, and might play an important role in the loss of hormone-dependence in breast cancer.
MeSH Terms
Breast Neoplasms/chemistry,genetics
DNA Methylation
DNA-Cytosine Methylases
Estrogen Receptor alpha
Exons
Female
Gene Expression Regulation, Neoplastic
Humans
Polymerase Chain Reaction
Promoter Regions, Genetic
Receptors, Estrogen/genetics
Receptors, Progesterone/analysis
Restriction Mapping
TATA Box
Chemicals
Estrogen Receptor alpha
Receptors, Estrogen
Receptors, Progesterone
DNA modification methylase HpaII
DNA-Cytosine Methylases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Iwase H
Department of Surgery II, Nagoya City University Medical School, Japan.
Omoto Y
Iwata H
Toyama T
Hara Y
Ando Y
Ito Y
Fujii Y
Kobayashi S
References (20)
20 references, click to expand
-
Oestrogen receptor gene structure and function in breast cancer.
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):529-36
PMID: 1562523
-
Estrogen receptor variants in clinical breast cancer.
Mol Endocrinol. 1991 Nov;5(11):1571-7
PMID: 1779964
-
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
Cancer Res. 1994 May 15;54(10):2552-5
PMID: 8168078
-
Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
J Natl Cancer Inst. 1995 Mar 15;87(6):446-51
PMID: 7861463
-
Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
Br J Cancer. 1995 Mar;71(3):448-50
PMID: 7880722
-
Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines.
Endocrinology. 1995 May;136(5):2223-9
PMID: 7720671
-
Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
Cancer Res. 1995 Jun 1;55(11):2279-83
PMID: 7538900
-
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
Cancer Res. 1995 Aug 1;55(15):3331-8
PMID: 7614468
-
Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Oncogene. 1995 Aug 3;11(3):475-84
PMID: 7630631
-
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Cancer Res. 1995 Oct 15;55(20):4531-5
PMID: 7553622
-
Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors.
Cancer Lett. 1996 Nov 29;108(2):179-84
PMID: 8973592
-
Two promoters in expression of estrogen receptor messenger RNA in human breast cancer.
Carcinogenesis. 1997 Mar;18(3):459-64
PMID: 9067542
-
William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.
Breast Cancer Res Treat. 1997 May;44(1):23-38
PMID: 9164675
-
Association between CpG island methylation and microsatellite instability in colorectal cancer.
Cancer Res. 1997 Aug 15;57(16):3370-4
PMID: 9269998
-
Alterations in DNA methylation: a fundamental aspect of neoplasia.
Adv Cancer Res. 1998;72:141-96
PMID: 9338076
-
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells.
J Biol Chem. 1997 Dec 19;272(51):32260-6
PMID: 9405430
-
Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells.
Br J Cancer. 1998;77(2):181-5
PMID: 9460986
-
Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Cancer Res. 1998 Jun 15;58(12):2515-9
PMID: 9635570
-
Estrogen receptor gene methylation in human breast tumors.
Cancer Res. 1990 Jul 1;50(13):3974-8
PMID: 2354445
-
Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Cancer Res. 1994 Jan 15;54(2):349-53
PMID: 8275466